Top 10 manufacturers in Glomerulonephritis Treatment Market
By Prof Researh
Updated 10:40:20 January 23, 2020
.
Updated 10:40:20 January 23, 2020
Prof Resear published a new Market report on Glomerulonephritis Treatment Market. It present the largest 10 manufacruers in Glomerulonephritis Treatment Market. The report is a professional and in-depth study on the current state of the global Glomerulonephritis Treatment market with a focus on the Chinese market. The report provides key statistics on market of Glomerulonephritis Treatment. It is a valuable source of guidance and direction for companies and individuals interested in Glomerulonephritis Treatment industry.
.
Achillion Pharmaceuticals Inc
Ref A: 0DDBF245D2B4455CBB067BBA541EC322 Ref B: SJCEDGE0419 Ref C: 2020-01-23T14:40:02Z
Anthera Pharmaceuticals Inc
Ref A: F874CA54BC7F4FD2929CAF2788104FB2 Ref B: SJCEDGE0415 Ref C: 2020-01-23T14:40:04Z
Biogen Inc
Ref A: 85AB64C20BF846AD984C80FB115AF27F Ref B: SJCEDGE0218 Ref C: 2020-01-23T14:40:06Z
Bristol-Myers Squibb Company
Ref A: 82D449200A7243F3BEA70580F9F40195 Ref B: SJCEDGE0407 Ref C: 2020-01-23T14:40:08Z
Cellmid Ltd
Ref A: D3841BC880194CC584EA4F1255E527A5 Ref B: SJCEDGE0216 Ref C: 2020-01-23T14:40:12Z
ChemoCentryx Inc
Ref A: A4AEF897D2654F889CE25DC305706556 Ref B: SJCEDGE0418 Ref C: 2020-01-23T14:40:13Z
Complexa Inc
Ref A: 876CA5471E0C4C48B1BA6AD25314E395 Ref B: SJCEDGE0212 Ref C: 2020-01-23T14:40:14Z
Dimerix Bioscience Pty Ltd
Dimerix develops new therapies through the clinic to commercialization. Our lead products are DMX-200 for FSGS and DMX-200 for diabetic kidney disease. Find out more . Dimerix is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. Home; About ... Dimerix Bioscience Pty Ltd . operates as a drug discovery company. The Company develops lead compounds to treat diseases in oncology, metabolic disorders, cardiovascular, and inflammation. Dimerix Bioscience Pty Ltd . operates as a drug discovery company. The Company develops lead compounds to treat diseases in oncology, metabolic disorders, cardiovascular, and inflammation.
GlaxoSmithKline Plc
Ref A: 168AD46F08604F27B9EA4506C60DE1F5 Ref B: SJCEDGE0412 Ref C: 2020-01-23T14:40:18Z
Merc
Ref A: B98E91CB728C423D975251832F57D5C5 Ref B: SJCEDGE0215 Ref C: 2020-01-23T14:40:19Z